Clinical Trial Update: Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting safety and efficacy findings for extended-release amantadine in levodopa-induced dyskinesia in Parkinson's disease from a Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Levodopa-induced Dyskinesia
• Parkinson Disease

Drugs mentioned

• amantadine extended-release (amantadine)

Snippet

Sponsor: Adamas Pharmaceuticals, Inc. | Conditions: Dyskinesia, Levodopa Induced Dyskinesia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-11-06